These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2598990)

  • 1. Application of a radioreceptor assay in a pharmacokinetic study of oxitropium bromide in healthy volunteers after single i.v., oral and inhalation doses.
    Ensing K; de Zeeuw RA; in 't Hout WG; Cornelissen PJ
    Eur J Clin Pharmacol; 1989; 37(5):507-12. PubMed ID: 2598990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of ipratropium bromide after single dose inhalation and oral and intravenous administration.
    Ensing K; de Zeeuw RA; Nossent GD; Koëter GH; Cornelissen PJ
    Eur J Clin Pharmacol; 1989; 36(2):189-94. PubMed ID: 2524387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biochemical studies with oxitropium bromide. 2. Pharmacokinetics and metabolism in humans].
    Wahl D; van Wayjen RG; van den Ende AA
    Arzneimittelforschung; 1985; 35(1A):266-72. PubMed ID: 4039167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incremental benefit of adding oxitropium bromide to formoterol in patients with stable COPD.
    Cazzola M; Di Perna F; Califano C; Vinciguerra A; D'Amato M
    Pulm Pharmacol Ther; 1999; 12(4):267-71. PubMed ID: 10501652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of nuvenzepine in human plasma by a sensitive [3H]pirenzepine radioreceptor binding assay.
    Caselli G; Ferrari MP; Tonon G; Clavenna G; Borsa M
    J Pharm Sci; 1991 Feb; 80(2):173-7. PubMed ID: 2051325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of inhalation or incubation of oxitropium bromide on diaphragm muscle contractility in mice.
    Shindoh C; Shishido R; Sasaki K; Miura M
    Allergol Int; 2011 Sep; 60(3):365-72. PubMed ID: 21593578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxitropium bromide improves exercise performance in patients with COPD.
    Ikeda A; Nishimura K; Koyama H; Sugiura N; Izumi T
    Chest; 1994 Dec; 106(6):1740-5. PubMed ID: 7988193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioreceptor assay for determination of the antimuscarinic drug ipratropium bromide in man.
    Ensinger HA; Wahl D; Brantl V
    Eur J Clin Pharmacol; 1987; 33(5):459-62. PubMed ID: 2962877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discontinuous oral absorption of cimetropium bromide, a new antispasmodic drug.
    Imbimbo BP; Daniotti S; Vidi A; Foschi D; Saporiti F; Ferrante L
    J Pharm Sci; 1986 Jul; 75(7):680-4. PubMed ID: 3761170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. A comparison of three different exercise tests.
    Oga T; Nishimura K; Tsukino M; Hajiro T; Ikeda A; Izumi T
    Am J Respir Crit Care Med; 2000 Jun; 161(6):1897-901. PubMed ID: 10852763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of nocturnal asthma by an inhaled anticholinergic drug.
    Coe CI; Barnes PJ
    Chest; 1986 Oct; 90(4):485-8. PubMed ID: 3530643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioreceptor assays of ipratropium bromide in plasma and urine.
    Ensing K; Pol M; De Zeeuw RA
    J Pharm Biomed Anal; 1988; 6(5):433-9. PubMed ID: 16867389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and bioavailability of drotaverine in humans.
    Bolaji OO; Onyeji CO; Ogundaini AO; Olugbade TA; Ogunbona FA
    Eur J Drug Metab Pharmacokinet; 1996; 21(3):217-21. PubMed ID: 8980918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of aerosol oxitropium bromide and fenoterol on maximal exercise capacity in chronic obstructive pulmonary disease and their correlation with air flow during exercise and with parameters of maximal exercise].
    Suruda T; Nakamura H; Kobayashi H; Uetani K; Nishio M; Higashimoto Y; Funasako M; Ohata M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Sep; 31(9):1089-95. PubMed ID: 8255017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary excretion of cimetropium bromide after multiple oral doses.
    Imbimbo BP; Piperno A; Fiorelli G; Muzio F; Daniotti S
    Eur J Clin Pharmacol; 1987; 33(3):337-8. PubMed ID: 3691626
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute effect of pretreatment with single conventional dose of salmeterol on dose-response curve to oxitropium bromide in chronic obstructive pulmonary disease.
    Cazzola M; Di Perna F; Centanni S; Califano C; Donner CF; D'Amato M; D'Amato G
    Thorax; 1999 Dec; 54(12):1083-6. PubMed ID: 10567627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased responses to inhaled oxitropium bromide in asthmatic patients with active hepatitis C virus infection.
    Kanazawa H; Hirata K; Yoshikawa J
    Chest; 2004 Apr; 125(4):1368-71. PubMed ID: 15078747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of trospium chloride.
    Doroshyenko O; Jetter A; Odenthal KP; Fuhr U
    Clin Pharmacokinet; 2005; 44(7):701-20. PubMed ID: 15966754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response study of oxitropium bromide inhaled as a nebulised solution.
    Stappaerts I; Van Schil L; Van der Veken J
    Eur J Clin Pharmacol; 1994; 46(4):305-7. PubMed ID: 7957513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sensitive radioreceptor assay for determining scopolamine concentrations in plasma and urine.
    Cintrón NM; Chen YM
    J Pharm Sci; 1987 Apr; 76(4):328-32. PubMed ID: 3598893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.